Resistance doesn’t end after kickoff—it evolves. To lead lasting transformation, CEOs must stop treating pushback as failure and start using it as fuel.

Despite the high stakes, more than half of boards and CEOs are not confident their succession planning is adequate.

How pharma and biotech leaders can navigate today’s challenging landscape—focusing on revamped approaches in business operations, talent strategy and development, and more to meet the evolving demands.

Organizations need a future-back approach to identifying potential, including simulations and key assessment methods, that goes beyond standard performance reviews.

The highest-performing teams steward conversation through three elements: goals, roles, and soul. Use this framework for greater clarity, stronger trust, and better decisions.

How moments-based simulations and AI role-play help leaders practice high-stakes conversations, build real behavior change, and give L&D predictive insight into performance.